ME01527B - Emulzijski cjepivni pripravci koji sadrže antigen i adjuvans u vodenoj fazi - Google Patents

Emulzijski cjepivni pripravci koji sadrže antigen i adjuvans u vodenoj fazi

Info

Publication number: ME01527B
Authority: ME; Montenegro
Prior art keywords: adjuvant; antigen; aqueous phase; vaccine compositions; emulsion vaccine
Prior art date: 2007-06-20

Application number

MEP-2013-101A

Other languages

English (en)

Inventor

David Leon Lutz

Jeffrey Harold Rodenberg

Evan James Diehl

Mahesh Kumar

Original Assignee

Zoetis Services Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-20

Filing date

2008-06-19

Publication date

2014-04-20

2008-06-19 Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc

2014-04-20 Publication of ME01527B publication Critical patent/ME01527B/me

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Virology (AREA)
Microbiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Dispersion Chemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

MEP-2013-101A 2007-06-20 2008-06-19 Emulzijski cjepivni pripravci koji sadrže antigen i adjuvans u vodenoj fazi ME01527B (me)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US93657107P	2007-06-20	2007-06-20
PCT/US2008/067433 WO2008157659A1 (en)	2007-06-20	2008-06-19	Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase
EP08771428.3A EP2164510B1 (en)	2007-06-20	2008-06-19	Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase

Publications (1)

Publication Number	Publication Date
ME01527B true ME01527B (me)	2014-04-20

Family

ID=39720537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-2013-101A ME01527B (me)	2007-06-20	2008-06-19	Emulzijski cjepivni pripravci koji sadrže antigen i adjuvans u vodenoj fazi

Country Status (26)

Country	Link
US (2)	US8980288B2 (me)
EP (1)	EP2164510B1 (me)
JP (2)	JP5457340B2 (me)
KR (1)	KR101569218B1 (me)
CN (2)	CN105148268A (me)
AR (1)	AR067087A1 (me)
AU (1)	AU2008265745B2 (me)
BR (1)	BRPI0812856A2 (me)
CA (1)	CA2692098C (me)
CL (1)	CL2008001806A1 (me)
CO (1)	CO6251273A2 (me)
CY (1)	CY1114451T1 (me)
DK (1)	DK2164510T3 (me)
ES (1)	ES2429296T3 (me)
HK (1)	HK1218717A1 (me)
HR (1)	HRP20130939T1 (me)
ME (1)	ME01527B (me)
MX (1)	MX2009014070A (me)
NZ (1)	NZ582132A (me)
PL (1)	PL2164510T3 (me)
PT (1)	PT2164510E (me)
RS (1)	RS52947B (me)
SI (1)	SI2164510T1 (me)
TW (1)	TWI507214B (me)
WO (1)	WO2008157659A1 (me)
ZA (1)	ZA200909173B (me)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2008001806A1 (es) *	2007-06-20	2008-09-05	Wyeth Corp	Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
KR101333852B1 (ko)	2008-06-27	2013-11-27	조에티스 엘엘씨	신규한 면역증강 조성물
WO2010114169A1 (en) *	2009-03-31	2010-10-07	Japan As Represented By The Director-General Of National Institute Of Infectious Diseases	Method for prophylaxis of influenza using vaccine for intranasal administration
CN102741537B (zh)	2010-01-29	2016-01-06	唐纳森公司	用于空气滤清器的水分离器组件及发动机空气流入口结构
CN101829323A (zh) *	2010-04-28	2010-09-15	洛阳普莱柯生物工程有限公司	一种禽用油乳剂疫苗及其制备方法
RU2013150203A (ru)	2011-04-12	2015-05-20	Оро Фину Партисипасойнс Э Эмпреендиментус С/А	Пептиды с противомикробной активностью, лекарственные композиции для лечения и профилактики животных, композиции для лечения и профилактики растений, применения указанных пептидов и применения экстракта из paenibacillus elgii ourofinensis
CN109675029A (zh) *	2013-09-19	2019-04-26	硕腾服务有限责任公司	油基佐剂
WO2015084594A1 (en) *	2013-12-06	2015-06-11	Advanced Bionutrition Corporation	Composition for oral delivery of bioactive agents
LT3244920T (lt)	2015-01-16	2023-08-25	Zoetis Services Llc	Snukio ir nagų ligos vakcina
GB201506948D0 (en) *	2015-04-23	2015-06-10	Croda Int Plc	Emulsions for injectable formulations
CN106177939B (zh) *	2015-06-01	2021-01-19	普莱柯生物工程股份有限公司	一种疫苗用佐剂及其应用
CN106344920B (zh) *	2015-07-16	2020-11-27	普莱柯生物工程股份有限公司	一种疫苗用佐剂及其应用
CN107281482B (zh) *	2016-04-05	2021-06-11	普莱柯生物工程股份有限公司	一种免疫佐剂组合物及其制备方法
CN112243373B (zh) *	2018-03-13	2023-09-22	胶囊技术私人有限公司	疫苗组合物
CN110404065B (zh) *	2018-04-27	2023-06-16	洛阳赛威生物科技有限公司	一种猪用佐剂组合物及其制备方法
US11813321B2 (en)	2018-07-13	2023-11-14	Biomune Company	Vaccines against avian reoviruses
BR112021001420A2 (pt)	2018-07-27	2021-05-04	Research Development Foundation	polipeptídeos imunogênicos quiméricos
CN114306585A (zh) *	2021-12-30	2022-04-12	广西壮族自治区水产科学研究院	一种鱼类高纯度抗原乳剂的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3639577A (en) *	1968-02-23	1972-02-01	Haver Lockhart Lab Inc	Injectable adjuvant,method of preparing same and compositions including such adjuvant
NZ221306A (en)	1986-08-15	1990-02-26	Commw Scient Ind Res Org	2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
DE3768232D1 (de) *	1986-12-19	1991-04-04	Duphar Int Res	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
US5951988A (en) *	1993-03-30	1999-09-14	University Of Saskatchewan	Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
BE1008977A5 (fr)	1994-12-27	1996-10-01	Solvay	Adjuvants pour vaccins.
US5744137A (en)	1995-02-06	1998-04-28	The United States Of America As Represented By The Secretary Of The Agriculture	Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
CA2314934C (en) *	1997-12-16	2006-08-29	Chiron Corporation	Use of microparticles combined with submicron oil-in-water emulsions
FR2775601B1 (fr) *	1998-03-03	2001-09-21	Merial Sas	Vaccins vivants recombines et adjuves
FR2776928B1 (fr)	1998-04-03	2000-06-23	Merial Sas	Vaccins adn adjuves
MXPA02011545A (es) *	2000-05-24	2003-06-06	Merial Sas	Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
FR2810888B1 (fr) *	2000-06-29	2004-07-30	Merial Sas	Vaccin contre la fievre aphteuse
US6585978B1 (en) *	2000-09-09	2003-07-01	Akzo Nobel	EIA vaccine and diagnostic
US7018638B2 (en)	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
US6676958B2 (en)	2001-06-19	2004-01-13	Advanced Bioadjuvants, Llc	Adjuvant composition for mucosal and injection delivered vaccines
US20030129161A1 (en)	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
JP3812814B2 (ja) *	2001-10-19	2006-08-23	株式会社微生物化学研究所	動物用多価オイルアジュバントワクチン
US7862821B2 (en)	2006-06-01	2011-01-04	Merial Limited	Recombinant vaccine against bluetongue virus
CL2008001806A1 (es) *	2007-06-20	2008-09-05	Wyeth Corp	Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.

2008
- 2008-06-18 CL CL200801806A patent/CL2008001806A1/es unknown
- 2008-06-19 BR BRPI0812856-1A2A patent/BRPI0812856A2/pt not_active IP Right Cessation
- 2008-06-19 PT PT87714283T patent/PT2164510E/pt unknown
- 2008-06-19 US US12/142,160 patent/US8980288B2/en active Active
- 2008-06-19 SI SI200831038T patent/SI2164510T1/sl unknown
- 2008-06-19 JP JP2010513396A patent/JP5457340B2/ja not_active Expired - Fee Related
- 2008-06-19 ES ES08771428T patent/ES2429296T3/es active Active
- 2008-06-19 EP EP08771428.3A patent/EP2164510B1/en active Active
- 2008-06-19 AU AU2008265745A patent/AU2008265745B2/en active Active
- 2008-06-19 CA CA2692098A patent/CA2692098C/en not_active Expired - Fee Related
- 2008-06-19 RS RS20130408A patent/RS52947B/en unknown
- 2008-06-19 ME MEP-2013-101A patent/ME01527B/me unknown
- 2008-06-19 DK DK08771428.3T patent/DK2164510T3/da active
- 2008-06-19 MX MX2009014070A patent/MX2009014070A/es active IP Right Grant
- 2008-06-19 NZ NZ582132A patent/NZ582132A/en not_active IP Right Cessation
- 2008-06-19 WO PCT/US2008/067433 patent/WO2008157659A1/en active Application Filing
- 2008-06-19 CN CN201510450651.5A patent/CN105148268A/zh active Pending
- 2008-06-19 KR KR1020107001106A patent/KR101569218B1/ko not_active IP Right Cessation
- 2008-06-19 CN CN200880024112A patent/CN101790378A/zh active Pending
- 2008-06-19 PL PL08771428T patent/PL2164510T3/pl unknown
- 2008-06-20 TW TW097123236A patent/TWI507214B/zh not_active IP Right Cessation
- 2008-06-20 AR ARP080102641A patent/AR067087A1/es not_active Application Discontinuation
2009
- 2009-12-17 CO CO09144676A patent/CO6251273A2/es not_active Application Discontinuation
- 2009-12-22 ZA ZA200909173A patent/ZA200909173B/xx unknown
2010
- 2010-11-09 HK HK16106725.1A patent/HK1218717A1/zh unknown
2013
- 2013-10-03 CY CY20131100855T patent/CY1114451T1/el unknown
- 2013-10-07 HR HRP20130939AT patent/HRP20130939T1/hr unknown
2014
- 2014-01-09 JP JP2014002096A patent/JP5802285B2/ja not_active Expired - Fee Related
2015
- 2015-02-10 US US14/618,628 patent/US9545439B2/en active Active

Also Published As

Publication number	Publication date
AU2008265745B2 (en)	2013-05-30
DK2164510T3 (da)	2013-09-23
TWI507214B (zh)	2015-11-11
CN101790378A (zh)	2010-07-28
JP5802285B2 (ja)	2015-10-28
US8980288B2 (en)	2015-03-17
US9545439B2 (en)	2017-01-17
CN105148268A (zh)	2015-12-16
CA2692098C (en)	2016-06-14
MX2009014070A (es)	2010-05-19
KR101569218B1 (ko)	2015-11-13
US20150297710A1 (en)	2015-10-22
SI2164510T1 (sl)	2013-11-29
CO6251273A2 (es)	2011-02-21
CY1114451T1 (el)	2016-10-05
AU2008265745A1 (en)	2008-12-24
AR067087A1 (es)	2009-09-30
RS52947B (en)	2014-02-28
WO2008157659A1 (en)	2008-12-24
EP2164510B1 (en)	2013-07-17
CA2692098A1 (en)	2008-12-24
JP2010530877A (ja)	2010-09-16
NZ582132A (en)	2012-04-27
ZA200909173B (en)	2010-08-25
PT2164510E (pt)	2013-10-07
CL2008001806A1 (es)	2008-09-05
KR20100022115A (ko)	2010-02-26
HRP20130939T1 (hr)	2013-11-22
US20090017067A1 (en)	2009-01-15
BRPI0812856A2 (pt)	2014-12-09
PL2164510T3 (pl)	2014-03-31
EP2164510A1 (en)	2010-03-24
HK1218717A1 (zh)	2017-03-10
TW200906448A (en)	2009-02-16
JP5457340B2 (ja)	2014-04-02
JP2014088423A (ja)	2014-05-15
ES2429296T3 (es)	2013-11-14

Publication	Publication Date	Title
ZA200909173B (en)	2010-08-25	Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase
EP1984405A4 (en)	2010-06-30	INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
EP1988918A4 (en)	2010-04-28	ADJUVANZ AND VACCINE COMPOSITIONS
IL213795A (en)	2013-05-30	An immunogenic preparation containing at least two different saccharides and a compound containing the aforementioned immunogenic preparation
IL197512A0 (en)	2011-08-01	Vaccine comprising an oil in water emulsion adjuvant
IL211131A0 (en)	2011-04-28	Inhbb epitope and vaccines containing the same
BRPI0815662A2 (pt)	2016-09-27	vacinas, antígenos, composições, e métodos profilácticos e terapêuticos para gripe
IL200859A0 (en)	2010-05-17	Oil-in-water emulsion influenza vaccine
EP1984388A4 (en)	2012-08-01	HPV ANTIGENES, VACCINE COMPOSITIONS AND RELATED METHODS
BRPI0814594A2 (pt)	2015-01-20	Composições e métodos adjuvantes de antígeno
ZA200808489B (en)	2009-10-28	Nicotine-carrier vaccine formulation
AP2010005173A0 (en)	2010-02-28	Compositions comprising pneumococcal antigens
EP2152301A4 (en)	2010-07-28	TRYPANOSOME ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
IL209967A0 (en)	2011-02-28	Cdca1 epitope peptides and vaccines containing the same
IL209027A0 (en)	2011-01-31	Vaccine compositions and uses thereof
HK1157204A1 (zh)	2012-06-29	表位肽及包含它們的疫苗
GB0615635D0 (en)	2006-09-13	Immunogenic proteins and uses thereof
EP2303909A4 (en)	2012-10-31	PEPTIDES EPITOPES DERIVED FROM IQGAP3 AND VACCINES CONTAINING THEM
HK1157397A1 (en)	2012-06-29	Rab6kifl/kif20a epitope peptide and vaccines containing the same rab6kifl/kif20a
ZA200802953B (en)	2009-01-28	Solid vaccine formulation
BRPI0717223A2 (pt)	2013-09-24	polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos
EP2054081A4 (en)	2010-07-21	VACCINE AGAINST THE JC VIRUS
TWI346557B (en)	2011-08-11	Adjuvant and vaccine includes the same
GB0504940D0 (en)	2005-04-20	Vaccine formulation
IL212945A0 (en)	2011-07-31	Wdrpuh epitope peptides and vaccines containing the same